ACADEMIC GRANTS
ACADEMIC GRANTS
The Leukemia & Lymphoma Society's (LLS's) academic grants support and encourage basic and translational leukemia, lymphoma and myeloma research.
LLS investigators are outstanding scientists at the forefront of leukemia, lymphoma and myeloma research at centers throughout the world. We award academic grants for studies that range from basic blood cancer research to research that uses the latest tools of genomics.
And we don't stop there. We're also dedicated to funding blood cancer research to help improve the quality of life for patients and their families with our projects studying long-term and late effects.
Information for Active Awardees
A resource for those with currently active LLS grants or awards.
LEARN MORE
LLS Research Spotlight
Highlighting brand new publications and advances produced by LLS-funded blood cancer research.
View
2019 Funded Researchers
See a list of the investigators whose projects were awarded funding in 2019.
VIEW LISTAcademic Grant Programs
Equity in Access
Supporting the generation of evidence that will guide changes in healthcare policy and practice to ensure that all patients with and survivors of a blood cancer achieve access to the cancer care and services they need throughout their lives.
HCL2025 guidelines
The HCLF and LLS joining forces to expanding research in Hairy Cell Leukemia to better characterize its biology, develop new therapies, and optimize outcomes for patients.
Download the 2019 Request For Proposals or
view our Statement on Future Research and Therapies for HCL.
Career Development Program (CDP) guidelines
Supporting talented young early-career physicians and scientists.
Go directly to the information page on the CDP application process or
browse our resources for current CDP awardees.
Translational Research Program (TRP) guidelines
LLS funds new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application: "Bench-to-Bedside".
Go directly to the information page on the TRP application process or
browse our resources for current TRP awardees.
Specialized Center of Research Program (SCOR) guidelines
Bringing together established investigators to develop a focused research program, foster new interactions and cooperation, as well as enhance interdisciplinary research.
Go directly to the information page on the SCOR application process or
browse our resources for current SCOR awardees.
Blood Cancer Discoveries Grant Program guidelines
Supporting groundbreaking early-stage research aimed to advance the treatment and cure of blood cancers and potentially other cancers as well.
Go directly to the information page on the Discovery application process or
browse our resources for current Discovery awardees.
LLS IMPACT guidelines
Expanding access to high-quality clinical trials to patients served by community health settings, particularly rural, minority, and/or economically disadvantaged blood cancer patients.
Go directly to the information page on the IMPACT application process or
browse our resources for current IMPACT awardees.
Screen to Lead Program (SLP) guidelines
Drug discovery support specifically directed towards medicinal chemistry and/or drug target screening in hematological malignancies.
Go directly to the information page on the SLP application process or
browse our resources for current SLP awardees.
RTFCCR/LLS Patient-Focused Prevention guidelines
The Rising Tide Foundation for Clinical Cancer Research and the Leukemia & Lymphoma Society partner in an international competitive grant to advance breakthroughs in prevention for blood cancers. The grant is focused on addressing four critical topics and is endowed with a total of USD $3 million.